Related Experiment Video
Updated: Feb 6, 2026

Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol
Published on: April 4, 2018
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1
Mohamed Jemaà1,2, Yasmin Abassi3, Chamseddine Kifagi4
1Department of Laboratory Medicine, Translational Cancer Research, Lund University, Lund, 22381, Sweden. jemaamohamed@gmail.com.
Abstract:
Colorectal cancer is one of the most commonly diagnosed cancers and the third most common cause of cancer-related death. Metastasis is the leading reason for the resultant mortality of these patients. Accordingly, development and characterization of novel anti-cancer drugs limiting colorectal tumor cell dissemination and metastasis are needed. In this study, we found that the small molecule Reversine reduces the migration potential of human colon carcinoma cells in vitro. A coupled kinase assay with bio-informatics approach identified the c-Jun N-terminal kinase (JNK) cascade as the main pathway inhibited by Reversine. Knockdown experiments and pharmacological inhibition identified JNK1 but not JNK2, as a downstream effector target in cancer cell migration. Xenograft experiments confirm the effect of JNK inhibition in the metastatic potential of colon cancer cells. These results highlight the impact of individual JNK isoforms in cancer cell metastasis and propose Reversine as a novel anti-cancer molecule for treatment of colon cancer patients.
Insights
The small molecule Reversine inhibits colon cancer cell migration by targeting the JNK1 pathway. This study identifies Reversine as a potential new drug to combat colorectal cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer-related death, with metastasis driving patient mortality.
- Novel therapeutic strategies are crucial to inhibit the dissemination and metastasis of colorectal tumor cells.
Purpose of the Study:
- To investigate the anti-metastatic effects of the small molecule Reversine on human colon carcinoma cells.
- To identify the molecular pathway targeted by Reversine in the context of cancer cell migration.
Main Methods:
- In vitro migration assays using human colon carcinoma cells.
- Kinase assays and bioinformatics analysis to identify the targeted signaling pathway.
- Gene knockdown and pharmacological inhibition of specific kinases.
- In vivo xenograft studies to assess metastatic potential.
Main Results:
- Reversine significantly reduced the migration potential of colon carcinoma cells in vitro.
- The c-Jun N-terminal kinase (JNK) cascade was identified as the primary pathway inhibited by Reversine.
- JNK1, but not JNK2, was identified as a key downstream effector in mediating Reversine's anti-migratory effects.
- Inhibition of JNK signaling in vivo reduced the metastatic potential of colon cancer cells.
Conclusions:
- Reversine demonstrates anti-metastatic properties by inhibiting JNK1-mediated cancer cell migration.
- This study highlights the differential roles of JNK isoforms in cancer metastasis.
- Reversine is proposed as a potential novel therapeutic agent for colorectal cancer treatment.
Related Concept Videos
Cell Migration
Cell Migration
Feedback Inhibition
The Colonization of Land
Cancer Cell Migration through Invadopodia
Chemotaxis and Direction of Cell Migration

